Leading fintech firm Pine Labs is gearing up to file its initial public offering (IPO) documents by mid-February. The company ...

Weight-loss drug developer Metsera is targeting an up to $1.78 billion valuation in its initial public offering, the ARCH Venture Partners-backed biotech company said on Monday. New York City-based ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

The initial public offerings of GB Logistics Commerce, and HM Electro Mech continued to get strong response from investors ...

With a $6.5 billion net worth, according to Forbes, Laffont cut his teeth at the well-known hedge fund Tiger Management, the ...

By Arasu Kannagi Basil (Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial public offering, set to be the first U.S.

Czech steam-turbine manufacturer Doosan Skoda Power AS launched an initial public offering, touting an outlook for high ...

The IPO share allotment will be finalised by January 28, while investors can start trading in CLN Energy shares on the BSE ...

On , Beijing Time, Qiming Venture Partners' portfolio company HyperStrong, a leading provider of battery energy storage systems (BESS) in China, successfully debuted on the Shanghai Stock Exchange's ...

Weight-loss drug developer Metsera on Monday said it was is targeting to raise as much as $292.2 million in an initial public offering.

Rexpro Enterprises IPO shows a grey market premium of ₹10, indicating a potential listing price of ₹155. The IPO was ...